Earnings Preview: Harrow Health
Portfolio Pulse from Benzinga Insights
Harrow Health (NASDAQ:HROW) is scheduled to release its quarterly earnings report on March 19, 2024, with analysts expecting an EPS of $-0.04. The company's past earnings performance shows a history of not meeting EPS estimates, leading to significant share price drops. Shares are currently trading at $10.49, down 42.21% over the last year. Investors will be closely watching for not only the earnings results but also the company's guidance for future growth.
March 18, 2024 | 2:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Harrow Health is expected to report an EPS of $-0.04 for the upcoming quarter. Historical performance shows significant price volatility post-earnings, with a notable 36.01% drop after last quarter's miss. Shares have declined 42.21% over the past year.
Given Harrow Health's history of not meeting EPS estimates and the subsequent negative impact on its share price, there is a high likelihood of a short-term negative impact on HROW's stock price if the company fails to meet or exceed the expected EPS. The anticipation of future guidance will also play a critical role in investor sentiment.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100